291 related articles for article (PubMed ID: 25920912)
1. The epidemiology, microbiology and clinical impact of Shiga toxin-producing Escherichia coli in England, 2009-2012.
Byrne L; Jenkins C; Launders N; Elson R; Adak GK
Epidemiol Infect; 2015 Dec; 143(16):3475-87. PubMed ID: 25920912
[TBL] [Abstract][Full Text] [Related]
2. The emerging importance of Shiga toxin-producing
Vishram B; Jenkins C; Greig DR; Godbole G; Carroll K; Balasegaram S; Byrne L
J Med Microbiol; 2021 Jul; 70(7):. PubMed ID: 34309502
[No Abstract] [Full Text] [Related]
3. Epidemiology and microbiology of Shiga toxin-producing Escherichia coli other than serogroup O157 in England, 2009-2013.
Byrne L; Vanstone GL; Perry NT; Launders N; Adak GK; Godbole G; Grant KA; Smith R; Jenkins C
J Med Microbiol; 2014 Sep; 63(Pt 9):1181-1188. PubMed ID: 24928216
[TBL] [Abstract][Full Text] [Related]
4. Increased recognition of non-O157 Shiga toxin-producing Escherichia coli infections in the United States during 2000-2010: epidemiologic features and comparison with E. coli O157 infections.
Gould LH; Mody RK; Ong KL; Clogher P; Cronquist AB; Garman KN; Lathrop S; Medus C; Spina NL; Webb TH; White PL; Wymore K; Gierke RE; Mahon BE; Griffin PM;
Foodborne Pathog Dis; 2013 May; 10(5):453-60. PubMed ID: 23560425
[TBL] [Abstract][Full Text] [Related]
5. Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome.
Werber D; Fruth A; Buchholz U; Prager R; Kramer MH; Ammon A; Tschäpe H
Eur J Clin Microbiol Infect Dis; 2003 Dec; 22(12):726-30. PubMed ID: 14614596
[TBL] [Abstract][Full Text] [Related]
6. The epidemiology of Shiga toxin-producing Escherichia coli infections in the South East of England: November 2013-March 2017 and significance for clinical and public health.
Carroll KJ; Harvey-Vince L; Jenkins C; Mohan K; Balasegaram S
J Med Microbiol; 2019 Jun; 68(6):930-939. PubMed ID: 30994441
[TBL] [Abstract][Full Text] [Related]
7. Estimating true incidence of O157 and non-O157 Shiga toxin-producing Escherichia coli illness in Germany based on notification data of haemolytic uraemic syndrome.
Kuehne A; Bouwknegt M; Havelaar A; Gilsdorf A; Hoyer P; Stark K; Werber D;
Epidemiol Infect; 2016 Nov; 144(15):3305-3315. PubMed ID: 27468812
[TBL] [Abstract][Full Text] [Related]
8. Shiga toxin-producing escherichia coli infections in Norway, 1992-2012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome.
Brandal LT; Wester AL; Lange H; Løbersli I; Lindstedt BA; Vold L; Kapperud G
BMC Infect Dis; 2015 Aug; 15():324. PubMed ID: 26259588
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological investigation of recurrent outbreaks of haemolytic uraemic syndrome caused by Shiga toxin-producing
Sawyer C; Vishram B; Jenkins C; Jorgensen F; Byrne L; Mikhail AFW; Dallman TJ; Carroll K; Ahyow L; Vahora Q; Godbole G; Balasegaram S
Epidemiol Infect; 2021 Apr; 149():e108. PubMed ID: 33866980
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006.
Espié E; Grimont F; Mariani-Kurkdjian P; Bouvet P; Haeghebaert S; Filliol I; Loirat C; Decludt B; Minh NN; Vaillant V; de Valk H
Pediatr Infect Dis J; 2008 Jul; 27(7):595-601. PubMed ID: 18520972
[TBL] [Abstract][Full Text] [Related]
11. Public Health Microbiology of Shiga Toxin-Producing Escherichia coli.
Caprioli A; Scavia G; Morabito S
Microbiol Spectr; 2014 Dec; 2(6):. PubMed ID: 26104435
[TBL] [Abstract][Full Text] [Related]
12. Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing
Bruyand M; Mariani-Kurkdjian P; Le Hello S; King LA; Van Cauteren D; Lefevre S; Gouali M; Jourdan-da Silva N; Mailles A; Donguy MP; Loukiadis E; Sergentet-Thevenot D; Loirat C; Bonacorsi S; Weill FX; De Valk H;
Euro Surveill; 2019 Feb; 24(8):. PubMed ID: 30808442
[TBL] [Abstract][Full Text] [Related]
13. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
Bruyand M; Mariani-Kurkdjian P; Gouali M; de Valk H; King LA; Le Hello S; Bonacorsi S; Loirat C
Med Mal Infect; 2018 May; 48(3):167-174. PubMed ID: 29054297
[TBL] [Abstract][Full Text] [Related]
14. Petting zoos as sources of Shiga toxin-producing Escherichia coli (STEC) infections.
Schlager S; Lepuschitz S; Ruppitsch W; Ableitner O; Pietzka A; Neubauer S; Stöger A; Lassnig H; Mikula C; Springer B; Allerberger F
Int J Med Microbiol; 2018 Oct; 308(7):927-932. PubMed ID: 30257809
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006.
Hedican EB; Medus C; Besser JM; Juni BA; Koziol B; Taylor C; Smith KE
Clin Infect Dis; 2009 Aug; 49(3):358-64. PubMed ID: 19548834
[TBL] [Abstract][Full Text] [Related]
16. Ten-year trends and risk factors for non-O157 Shiga toxin-producing Escherichia coli found through Shiga toxin testing, Connecticut, 2000-2009.
Hadler JL; Clogher P; Hurd S; Phan Q; Mandour M; Bemis K; Marcus R
Clin Infect Dis; 2011 Aug; 53(3):269-76. PubMed ID: 21765075
[TBL] [Abstract][Full Text] [Related]
17. Serogroup-specific risk factors for Shiga toxin-producing Escherichia coli infection in Australia.
McPherson M; Lalor K; Combs B; Raupach J; Stafford R; Kirk MD
Clin Infect Dis; 2009 Jul; 49(2):249-56. PubMed ID: 19522658
[TBL] [Abstract][Full Text] [Related]
18. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli.
Mody RK; Luna-Gierke RE; Jones TF; Comstock N; Hurd S; Scheftel J; Lathrop S; Smith G; Palmer A; Strockbine N; Talkington D; Mahon BE; Hoekstra RM; Griffin PM
Arch Pediatr Adolesc Med; 2012 Oct; 166(10):902-9. PubMed ID: 22869280
[TBL] [Abstract][Full Text] [Related]
19. Ongoing haemolytic uraemic syndrome (HUS) outbreak caused by sorbitol-fermenting (SF) Shiga toxin-producing Escherichia coli (STEC) O157, Germany, December 2016 to May 2017.
Vygen-Bonnet S; Rosner B; Wilking H; Fruth A; Prager R; Kossow A; Lang C; Simon S; Seidel J; Faber M; Schielke A; Michaelis K; Holzer A; Kamphausen R; Kalhöfer D; Thole S; Mellmann A; Flieger A; Stark K
Euro Surveill; 2017 May; 22(21):. PubMed ID: 28597831
[TBL] [Abstract][Full Text] [Related]
20. Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009-2012.
Launders N; Byrne L; Jenkins C; Harker K; Charlett A; Adak GK
BMJ Open; 2016 Jan; 6(1):e009933. PubMed ID: 26826153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
